These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22355530)

  • 1. Mechanism of copper(II)-induced misfolding of Parkinson's disease protein.
    Rose F; Hodak M; Bernholc J
    Sci Rep; 2011; 1():11. PubMed ID: 22355530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinorganic Chemistry of Parkinson's Disease: Affinity and Structural Features of Cu(I) Binding to the Full-Length β-Synuclein Protein.
    Miotto MC; Pavese MD; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO
    Inorg Chem; 2017 Sep; 56(17):10387-10395. PubMed ID: 28820253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Α-synuclein misfolding and Parkinson's disease.
    Breydo L; Wu JW; Uversky VN
    Biochim Biophys Acta; 2012 Feb; 1822(2):261-85. PubMed ID: 22024360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study.
    Bharathi ; Indi SS; Rao KS
    Neurosci Lett; 2007 Sep; 424(2):78-82. PubMed ID: 17714865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific copper-catalyzed oxidation of α-synuclein: tightening the link between metal binding and protein oxidative damage in Parkinson's disease.
    Miotto MC; Rodriguez EE; Valiente-Gabioud AA; Torres-Monserrat V; Binolfi A; Quintanar L; Zweckstetter M; Griesinger C; Fernández CO
    Inorg Chem; 2014 May; 53(9):4350-8. PubMed ID: 24725094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Nucleation of Polymorphic α-Synuclein Dimers Depends on Copper Concentrations and Definite Copper-Binding Site.
    Blacher C; Abramov-Harpaz K; Miller Y
    Biomolecules; 2024 May; 14(6):. PubMed ID: 38927031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine binds to α-synuclein and causes a conformational change which can be detected by nanopore analysis.
    Tavassoly O; Lee JS
    FEBS Lett; 2012 Sep; 586(19):3222-8. PubMed ID: 22771474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease.
    Li Y; Yang C; Wang S; Yang D; Zhang Y; Xu L; Ma L; Zheng J; Petersen RB; Zheng L; Chen H; Huang K
    Int J Biol Macromol; 2020 Nov; 163():562-573. PubMed ID: 32629061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinorganic chemistry of Parkinson's disease: structural determinants for the copper-mediated amyloid formation of alpha-synuclein.
    Binolfi A; Rodriguez EE; Valensin D; D'Amelio N; Ippoliti E; Obal G; Duran R; Magistrato A; Pritsch O; Zweckstetter M; Valensin G; Carloni P; Quintanar L; Griesinger C; Fernández CO
    Inorg Chem; 2010 Nov; 49(22):10668-79. PubMed ID: 20964419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-Terminal Cu
    Abeyawardhane DL; Heitger DR; Fernández RD; Forney AK; Lucas HR
    ACS Chem Neurosci; 2019 Mar; 10(3):1402-1410. PubMed ID: 30384594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamics imprinting reveals differential binding of metals to alpha-synuclein: relevance to Parkinson's disease.
    Bharathi ; Rao KS
    Biochem Biophys Res Commun; 2007 Jul; 359(1):115-20. PubMed ID: 17531952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cu
    Ramis R; Ortega-Castro J; Vilanova B; Adrover M; Frau J
    Int J Biol Macromol; 2021 Feb; 169():251-263. PubMed ID: 33345970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cu2+ binding modes of recombinant alpha-synuclein--insights from EPR spectroscopy.
    Drew SC; Leong SL; Pham CL; Tew DJ; Masters CL; Miles LA; Cappai R; Barnham KJ
    J Am Chem Soc; 2008 Jun; 130(24):7766-73. PubMed ID: 18494470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordination and redox properties of copper interaction with α-synuclein.
    Valensin D; Dell'Acqua S; Kozlowski H; Casella L
    J Inorg Biochem; 2016 Oct; 163():292-300. PubMed ID: 27112900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders.
    Lu Y; Prudent M; Fauvet B; Lashuel HA; Girault HH
    ACS Chem Neurosci; 2011 Nov; 2(11):667-75. PubMed ID: 22860160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein.
    Teng Y; Zhao J; Ding L; Ding Y; Zhou P
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31416122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N Terminus of α-Synuclein Forms Cu(II)-Bridged Oligomers.
    Drew SC
    Chemistry; 2015 May; 21(19):7111-8. PubMed ID: 25757154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of a high affinity mononuclear site in the copper(II)-α-synuclein complex.
    Bortolus M; Bisaglia M; Zoleo A; Fittipaldi M; Benfatto M; Bubacco L; Maniero AL
    J Am Chem Soc; 2010 Dec; 132(51):18057-66. PubMed ID: 21141829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.